Low-dose aspirin was associated with reduced risk of dementia in women but not men with diabetes, and long-term use of metformin was associated with lower risk of Alzheimer's disease among patients with diabetes.
Studies published in July looked at factors and conditions associated with variation in glycemic control between clinic visits, including diabetes treatment intensity and Alzheimer's disease.
Mortality and cardiovascular complications from diabetes have gone down, but incidence rates among youth are up, according to recent studies of Swedish and American patients, respectively.
Two studies compared heart failure rates in patients with and without type 2 diabetes, while a third looked at the risk of heart failure associated with various classes of glucose-lowering drugs.
Recent studies looked at prevalence of diagnosed diabetes in the U.S.; trends in hospitalization for diabetic ketoacidosis; and the prevalence of obesity, metabolic syndrome, and diabetes.
Recent studies looked at vitamin D supplementation, peer mentoring, and physician referrals to diabetes prevention programs among patients with prediabetes.
The effects of sodium-glucose cotransporter-2 (SGLT-2) inhibitors on heart failure, in patients with and without diabetes, were the focus of three analyses published in the past month, two on dapagliflozin and one on canagliflozin.
Multiple recent studies focused on HIV and diabetes, looking at incidence of diabetes among patients with HIV, the effectiveness of medications in patients with both conditions, and efforts to improve nutrition in patients with one or both conditions
Recent studies looked at diabetic retinopathy's associations with age-related macular degeneration, chronic kidney disease, and different classes of diabetes drugs.
Two recent studies looked at the incidence of hypoglycemia among patients with diabetes around the world, while another offered an intervention to reduce hypoglycemia in patients with impaired awareness of it.